TotalMarketCap

Psyence Biomedical

PBMNasdaq CanadaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$15.628 M

$2.94 -7.55%

Close of 6 Nov 2026

As of 6 Nov 2026, Psyence Biomedical (PBM) has a market capitalization of $15.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

2,293,277

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Psyence Biomedical lists more than one class of stock. Company figures above cover all classes combined.

PBMWW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #392Pasithea TherapeuticsKTTA$16.8M
  2. #393NewcelXNCEL$16.4M
  3. #394Psyence BiomedicalPBM$15.6M
  4. #395Citius PharmaceuticalsCTXR$15.4M
  5. #396Allarity TherapeuticsALLR$15.3M

What if Psyence Biomedical were worth as much as…

Open the what-if tool →

Gold $28.2T

$5,312,049

Per share 1,806,819× higher

Bitcoin $1.53T

$287,425.70

Per share 97,764× higher

Apple $5.02T

$943,591.75

Per share 320,950× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Psyence Biomedical are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.